Radio-Isotope Therapy of America (RITA) Foundation is a non-profit charitable organization (IRS 501c-3) that was registered in the State of Texas on February 2, 2004, and received its charitable status in December of 2004. RITA Foundation has the following goals and initiatives in both clinical and research area to fight against cancer:

1 Discounted Digital Mammography for Breast Cancer

Provide screening for breast cancer which is the most common cancer in women. RITA Foundation in collaboration with Westchase Imaging, Ltd. is the first free standing, nonprofit charitable organization in Houston to offer “Digital Mammography” for screening breast cancer in women. This imaging modality has significantly higher resolution and can diagnose cancer at a very early stage, with much lower radiation as compared with analog mammography. Patients can self refer for screening. Qualified patients can receive the service free of charge or at a significantly discounted price.

2 High-Res Scans for Early Diagnosis of Lung Cancer

RITA foundation in collaboration with Westchase Imaging, Ltd. is also offering high resolution CT-64 slice scan of the lungs for early diagnosis of lung cancer.

3 New Drugs Research for Neuroendocrine Cancers

RITA Foundation supports Investigational New Drug (IND) applications permitted by FDA for treatment of neuroendocrine cancers. These treatments are offered in collaboration with Excel Diagnostics, in Houston, BioSynthema corporation based in St. Luis Missouri and its parent company Advanced Accelerator Applications(AAA) based in France, Missouri University Research Reactor (MURR), IsoTherapeutics Group (ITG) in Angelton, Texas, IsoTexs in Friendswood, Radiomedix, Inc in Houston Texas, and South Texas Radio-Pharmacy, Baylor College of Medicine, and St. Luke’s Episcopal Hospital in Houston.Lu-177 Octreotate which has been available in Europe and Australia for many years and up to now patients had to go to Europe to receive this treatment.This physician sponsored IND will allow our patient to receive treatment in U.S.A.


4 Targeted Radionuclide Therapy for "Orphan Diseases"

RITA also sponsors Novel Basic Research projects. These projects involve labeling novel biochemical agents with therapeutic radioactive materials to create compounds for diagnosis and therapy of cancer. This is also called “targeted radionuclide therapy” which is believed to be the wave of the future in treatment of cancer. RITA’s special focus is on research on FDA designated “Orphan Diseases". These are diseases that because of their lower prevalence are not attractive for typical pharmaceutical companies for research and development.

5 Educate Public on Early Diagnosis of Cancer

RITA also educates the public regarding screening and early diagnosis of cancer and information about new targeted and personalized therapy of cancer by organizing educational seminars through it’s outreach program.

RITA Scientific Team

Ebrahim S. Delpassand, M.D.
Izabela Tworowska, PhD.
Jennifer Sims Mourtada, PhD.
Sara Zamanian, M.D.
Sanjay Thamake, PhD.
David Ranganathan, PhD.
Amin Samarghandi, M.D.

RITA Board of Directors


Azar I. Delpassand

Vice President:

Nasrin Hakim


Al Lalani


Susan Cork

Board Member:

Jennifer Sims, PhD.

RITA Independent Consultants


Raj Brahmbhatt, CPA


Michael Rubenstein, Schlanger, Mills, Mayer & Silver, LLP

RITA Supporters & Contributers


Westchase Imaging, LTD


Excel Diagnostics & Nuclear Oncology Center, LTD WEBSITE


The Carcinoid Cancer Foundation, Inc. WEBSITE


Ebrahim S. Delpassand, M.D.
5Our patients, their relatives and their friends.
6Other charitable organization.

RITA Non-Profit Charitable Status 501(c)(3)

RITA Foundation is a non-profit 501(c)(3) charitable organization that was registered in the State of Texas on February 2, 2004, and received its charitable status in December of 2004. Click Here to view the approval letters from State of Texas and Internal Revenue Services, IRS.

RITA Logo Information

RITA Foundation's logo consists of a White Ribbon forming an "R" symbolizing cancer awareness, complimented by the Sun, symbolizing hope for tomorrow.

The RITA Foundation hereby licenses its copyrighted logo for non-commercial uses such as: a) A logo to identify RITA related web pages, links to RITA website, and other references to RITA Foundation, or b) As a logo to identify RITA related content in presentations given at conferences. RITA Foundation reserves the right to revoke this license at any time.